Phase 2 trial of neoadjuvant docetaxel, oxaliplatin, and S‐1 for clinical stage III gastric or esophagogastric junction adenocarcinoma

por Kurokawa, Yukinori, Kawase, Tomono, Takeno, Atsushi, Furukawa, Haruna, Yoshioka, Ryo, Saito, Takuro, Takahashi, Tsuyoshi, Shimokawa, Toshio, Eguchi, Hidetoshi, Doki, Yuichiro
Publicado 2022

Effect of Target Lesion Revascularization on Restenosis Lesions of the Superficial Femoral Artery without Recurred Symptoms after Endovascular Therapy

por Utsunomiya, Makoto, Takahara, Mitsuyoshi, Fujihara, Masahiko, Shiraki, Tatsuya, Kozuki, Amane, Fukunaga, Masashi, Tan, Michinao, Yoshioka, Ryo, Tomoi, Yusuke, Mori, Shinsuke, Iwasaki, Yusuke, Sasaki, Shinya, Nakamura, Masato
Publicado 2021

Efficacy and impact of SARS-CoV-2 vaccination on cancer treatment for breast cancer patients: a multi-center prospective observational study

por Terada, Mitsuo, Kondo, Naoto, Wanifuchi-Endo, Yumi, Fujita, Takashi, Asano, Tomoko, Hisada, Tomoka, Uemoto, Yasuaki, Akiko Kato, Yamanaka, Natsumi, Sugiura, Hiroshi, Mita, Keiko, Wada, Asaka, Takahashi, Eriko, Saito, Kanako, Yoshioka, Ryo, Toyama, Tatsuya
Publicado 2022

Predictive Value of the Cardio‐Ankle Vascular Index for Cardiovascular Events in Patients at Cardiovascular Risk

por Miyoshi, Toru, Ito, Hiroshi, Shirai, Kohji, Horinaka, Shigeo, Higaki, Jitsuo, Yamamura, Shigeo, Saiki, Atsuhito, Takahashi, Mao, Masaki, Mitsuru, Okura, Takafumi, Kotani, Kazuhiko, Kubozono, Takuro, Yoshioka, Ryo, Kihara, Hajime, Hasegawa, Koji, Satoh‐Asahara, Noriko, Orimo, Hajime
Publicado 2021

YES1 as a Therapeutic Target for HER2-Positive Breast Cancer after Trastuzumab and Trastuzumab-Emtansine (T-DM1) Resistance Development

por Fujihara, Miwa, Shien, Tadahiko, Shien, Kazuhiko, Suzawa, Ken, Takeda, Tatsuaki, Zhu, Yidan, Mamori, Tomoka, Otani, Yusuke, Yoshioka, Ryo, Uno, Maya, Suzuki, Yoko, Abe, Yuko, Hatono, Minami, Tsukioki, Takahiro, Takahashi, Yuko, Kochi, Mariko, Iwamoto, Takayuki, Taira, Naruto, Doihara, Hiroyoshi, Toyooka, Shinichi
Publicado 2021